D&D Pharmacy dispenses NAD+, sermorelin, tesamorelin, glutathione, B12 and other wellness injections, compounded to order. BPC-157, TB-500, KPV, MOTS-c, Epitalon and Semax cannot be compounded yet; the guide below tracks where each one stands. Call or WhatsApp a pharmacist, en español también.
Each therapy is compounded to order. Price depends on strength, frequency and quantity; call or WhatsApp for a quote.
A coenzyme every cell uses to turn food into energy; levels fall with age. Used in longevity and recovery protocols.
A growth hormone-releasing peptide that prompts the pituitary to release your own growth hormone. Usually injected at bedtime.
An antioxidant the body makes from three amino acids. Used in antioxidant and wellness protocols, often with vitamin C.
B vitamins for energy metabolism, nerve function and red-blood-cell production. An injection skips the gut, useful when absorption is poor.
Long-acting testosterone for clinically diagnosed low testosterone. Dosed weekly or every two weeks, with lab monitoring by your prescriber.
A form of vitamin B12 for energy and nerve function. B12 deficiency is more common in vegans, older adults and people on metformin or acid reducers.
High-dose vitamin C (ascorbic acid) for immune and collagen support. Injection reaches higher blood levels than oral vitamin C.
B12, vitamin C, magnesium and zinc in one injection, used after illness, travel or hard training.
Methionine, inositol and choline (MIC) with methyl-B12, B3 and L-carnitine. A lipotropic injection used alongside a weight-management plan.
Tesamorelin is available by prescription. BPC-157, TB-500, KPV and MOTS-c received a favorable FDA advisory-committee vote in July 2026 but can't be compounded until FDA finalizes the rule. Injectable GHK-Cu is still under FDA review; topical GHK-Cu can be compounded. See each peptide's status ↓
A GHRH analog and the active ingredient in FDA-approved Egrifta. Raises your own growth hormone; best known for reducing abdominal (visceral) fat.
A peptide derived from a protective stomach protein, studied for gut lining, tendon, ligament and soft-tissue repair.
A synthetic fragment of thymosin beta-4, the protein the body uses for cell migration and repair. Studied for injury recovery.
A three-amino-acid peptide (lysine–proline–valine) from alpha-MSH, studied for calming inflammation in the gut and skin.
A mitochondrial-derived peptide that acts as a metabolic signal, studied for insulin sensitivity and exercise capacity.
Retatrutide is waiting on FDA approval. Epitalon and Semax received favorable FDA advisory-committee votes in July 2026 and await final FDA action. Call or WhatsApp to be notified when each can be dispensed.
Eli Lilly's GIP, GLP-1 and glucagon "triple agonist" for weight loss. Not FDA-approved; Lilly plans to submit it to FDA in early 2027.
A four-amino-acid peptide modeled on a pineal-gland extract, studied for sleep and circadian rhythm.
FDA changed peptide compounding rules several times in 2026. We update this guide when FDA acts.
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme every cell uses to turn food into energy. Levels decline with age. Injectable NAD+ is used in longevity and recovery protocols; injecting too fast can cause flushing, nausea or chest tightness, so dosing is started slowly.
Status: Available now · compounded to order
Sermorelin is a peptide copy of the first 29 amino acids of growth hormone-releasing hormone (GHRH). It prompts the pituitary to release the body's own growth hormone rather than supplying it directly, and is usually injected under the skin at bedtime.
Status: Available now · compounded to order
Tesamorelin is a synthetic GHRH analog and the active ingredient in Egrifta, which FDA approved to reduce excess abdominal fat in adults with HIV-associated lipodystrophy. It raises the body's own growth hormone and IGF-1. It is injected daily and requires a prescription.
Status: FDA-approved ingredient · prescription required
BPC-157 (Body Protection Compound-157) is a 15-amino-acid peptide derived from a protein in human gastric juice. It has been studied mostly in animals, for gut-lining protection and tendon, ligament and muscle repair; human clinical data are limited.
Status: Removed from FDA's Category 2 list in April 2026. FDA's advisory committee voted 8–6 in July 2026 to add it to the 503A bulks list. Not yet compoundable: FDA must finalize the change through rulemaking.
TB-500 is a synthetic fragment of thymosin beta-4, a protein involved in cell migration, blood-vessel formation and tissue repair. It is studied for soft-tissue recovery and is often discussed with BPC-157.
Status: Removed from FDA's Category 2 list in April 2026. FDA's advisory committee voted 8–6 in July 2026 to add it to the 503A bulks list. Not yet compoundable: FDA must finalize the change through rulemaking.
KPV is a three-amino-acid peptide (lysine–proline–valine) from the tail of alpha-melanocyte-stimulating hormone (alpha-MSH). It is studied for anti-inflammatory effects in the gut and skin.
Status: Removed from FDA's Category 2 list in April 2026. FDA's advisory committee voted 8–6 in July 2026 to add it to the 503A bulks list. Not yet compoundable: FDA must finalize the change through rulemaking.
MOTS-c is a 16-amino-acid peptide encoded by mitochondrial DNA. It acts as a metabolic signal and is studied for insulin sensitivity, glucose metabolism and exercise capacity.
Status: Removed from FDA's Category 2 list in April 2026. FDA's advisory committee voted 7–5 in July 2026 to add it to the 503A bulks list. Not yet compoundable: FDA must finalize the change through rulemaking.
GHK-Cu (copper tripeptide-1) is a naturally occurring peptide that binds copper; levels decline with age. It is best known for skin use: collagen and elastin support, firmness and wound healing.
Status: Topical GHK-Cu: on FDA's Category 1 list, so it can be compounded. Injectable GHK-Cu: removed from Category 2 in April 2026, with an advisory-committee review expected by February 2027.
Epitalon (also spelled epithalon) is a four-amino-acid peptide modeled on a pineal-gland extract. It is studied for sleep, circadian rhythm and aging; human data are limited.
Status: Removed from FDA's Category 2 list in April 2026. FDA's advisory committee voted 7–4 in July 2026 to add it to the 503A bulks list. Not yet compoundable: FDA must finalize the change through rulemaking.
Semax is a synthetic peptide derived from a fragment of ACTH (adrenocorticotropic hormone). It is used clinically in Russia and studied for attention, memory and stroke recovery.
Status: Removed from FDA's Category 2 list in April 2026. FDA's advisory committee voted 8–5 in July 2026 to add it to the 503A bulks list. Not yet compoundable: FDA must finalize the change through rulemaking.
Retatrutide (LY3437943) is an investigational once-weekly injection from Eli Lilly that activates three receptors: GIP, GLP-1 and glucagon. Lilly plans to submit it to FDA in the first quarter of 2027. It is not FDA-approved and cannot legally be compounded; "research-use" vials sold online are unapproved and unregulated.
Status: Investigational · not FDA-approved
Educational information, not medical advice. Peptide therapy should be prescribed and monitored by a licensed provider.
Already work with a provider? Loop them in. If not, we connect you with a Florida-licensed telehealth clinician.
Your medications, allergies and goals are checked by phone or in person before anything is prepared.
Compounded for you by our sterile-compounding partner and kept cold until it reaches you.
Pick up at 9787 SW 72nd St or get free same-day delivery in Miami-Dade, with injection instructions included.
We'll tell you what's available, what it costs and what still isn't legal to dispense.
Compounded to order · call (786) 558-0702 or WhatsApp us to get started.
